At a glance
ClinicalIndex Comparison RecordN/ACompleted· 24 enrolled
Drug / intervention
Delivery Lumen Access Device +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Safety and Clinical Validation Study of the Plan A Delivery Lumen Access Device (DLAD)
In Brief
A clinical study evaluating Delivery Lumen Access Device and DLAD for Healthy Male Adults Participants and Vasectomy. Completed, enrolled 24 participants across 2 sites in 2 countries.
Detailed Summary
This study will evaluate the safety and usability of the Delivery Lumen Access Device (DLAD) in accessing the vas deferens in up to 30 healthy males. This is a prospective, non-randomized, open label interventional study.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy Male Adults Participants, Vasectomy
CountriesAustralia, Canada
CollaboratorsSouthern Star Research
Timeline
N/ACompletedFinished
2026
Enrollment StartMar 2025
First PostedMar 2025
Primary CompletionJun 2025
Study CompletionJun 2025
TodayJul 2026
First PostedMar 24, 2025
Enrollment StartMar 15, 2025
Primary CompletionJun 29, 2025
Study CompletionJun 30, 2025
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 1.3 years ago
Interventions
Delivery Lumen Access Devicedevice
Delivery Lumen Access Device use prior to Vasectomy
DLADdevice
Participants will be exposed to the DLAD during their planned vasectomy